open access

Vol 24, No 6 (2019)
Reviews
Published online: 2019-11-01
Submitted: 2018-10-31
Get Citation

Human Papillomavirus and the use of nanoparticles for immunotherapy in HPV-related cancer: A review

Michael Jakob Rupar, Pawel Golusinski, Wojciech Golusinski, Michal M. Masternak
DOI: 10.1016/j.rpor.2019.08.006
·
Rep Pract Oncol Radiother 2019;24(6):544-550.

open access

Vol 24, No 6 (2019)
Reviews
Published online: 2019-11-01
Submitted: 2018-10-31

Abstract

Human Papillomavirus (HPV) remains one of the most commonly contracted sexually transmitted diseases around the world. There are a multitude of HPV types, some of which may never present any symptoms. Others, however, are considered high-risk types, which increase the chance of the person infected to develop cancer. In recent years, the utilization of nanotechnology has allowed researchers to employ and explore the use of nanoparticles in immunotherapies.

The new nanoparticle frontier has opened many doors in this area of research as a form of prevention, diagnosis, and treatment in cancers resulting from HPV. This review will provide a brief background of HPV, its relationship to head and neck cancer (HNC) and present some insight into the field of immunotherapeutic nanoparticles.

Abstract

Human Papillomavirus (HPV) remains one of the most commonly contracted sexually transmitted diseases around the world. There are a multitude of HPV types, some of which may never present any symptoms. Others, however, are considered high-risk types, which increase the chance of the person infected to develop cancer. In recent years, the utilization of nanotechnology has allowed researchers to employ and explore the use of nanoparticles in immunotherapies.

The new nanoparticle frontier has opened many doors in this area of research as a form of prevention, diagnosis, and treatment in cancers resulting from HPV. This review will provide a brief background of HPV, its relationship to head and neck cancer (HNC) and present some insight into the field of immunotherapeutic nanoparticles.

Get Citation

Keywords

Cancer; HPV; HNC; Nanoparticle; Immunotherapy

About this article
Title

Human Papillomavirus and the use of nanoparticles for immunotherapy in HPV-related cancer: A review

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 24, No 6 (2019)

Pages

544-550

Published online

2019-11-01

DOI

10.1016/j.rpor.2019.08.006

Bibliographic record

Rep Pract Oncol Radiother 2019;24(6):544-550.

Keywords

Cancer
HPV
HNC
Nanoparticle
Immunotherapy

Authors

Michael Jakob Rupar
Pawel Golusinski
Wojciech Golusinski
Michal M. Masternak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl